Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

503
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
503

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Academic Preparation and Internship Expectations for Clinical Exercise Physiologist: FOCUS ON CARDIOPULMONARY REHABILITATION PROGRAMS.

Journal of cardiopulmonary rehabilitation and prevention·2026
Same author

Humanistic Machines: Designing Devices for People With Heart Failure With a Focus on Multidisciplinary Human Factors Research.

JACC. Heart failure·2026
Same author

Rationale and Design of RECOVER-ENERGIZE: A Platform Clinical Trial of Interventions for Exercise Intolerance With and Without Post-exertional Malaise in Long COVID.

medRxiv : the preprint server for health sciences·2026
Same author

Ambulatory Stage C2D Heart Failure Definitions and Current Therapeutic Approaches: JACC: Heart Failure Position Statement.

JACC. Heart failure·2026
Same author

The Role of Mechanical Circulatory Support Devices in Heart Failure Cardiogenic Shock.

Interventional cardiology clinics·2026
Same author

Double jeopardy: The plight of the durable LVAD patient waiting for heart transplant in the United States.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same journal

The HELP Score in Non-Asphyxial Hypothermic Cardiac Arrest Treated With Extracorporeal Life Support: External Validation and Clinical Utility.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same journal

Incidence and Mortality Outcomes of Extracorporeal Membrane Oxygenation in Infants With Congenital Lung Malformations: A Registry Study.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same journal

Hemolysis During Microaxial Flow Pump Support: Cause or Marker of Hemocompatibility-Related Adverse Events After Left Ventricular Assist Device Implantation?

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same journal

Machine Learning Prediction of Pediatric In-Hospital Survival Before Extracorporeal Membrane Oxygenation Cannulation.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same journal

Erratum: Safety and Efficacy of Stored Wet-Preprimed Extracorporeal Membrane Oxygenation Circuits: A Scoping Review.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same journal

Case Series of Extracorporeal Cardiopulmonary Resuscitation for Refractory Cardiopulmonary Arrest After Cardiac Surgery.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
See all related articles

Related Experiment Video

Updated: Jul 3, 2025

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
05:18

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

Published on: November 22, 2024

522

Bridge to Weight Loss: A Case Series.

Robert A Solomon1, Dennis J Kerrigan, Steven J Keteyian

  • 1From the Division of Cardiovascular Medicine, Henry Ford Hospital, Detroit, Michigan.

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|February 12, 2024
PubMed
Summary
This summary is machine-generated.

Patients with left ventricular assist devices (LVADs) can achieve significant weight loss through multidisciplinary strategies, enabling them to qualify for heart transplantation (HT). This approach addresses obesity as a barrier to HT eligibility.

More Related Videos

A Protocol for Roux-en-Y Gastric Bypass in Rats using Linear Staplers
11:58

A Protocol for Roux-en-Y Gastric Bypass in Rats using Linear Staplers

Published on: August 21, 2021

5.4K
Sleeve Gastrectomy in Mice using Surgical Clips
05:16

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

6.6K

Related Experiment Videos

Last Updated: Jul 3, 2025

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
05:18

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

Published on: November 22, 2024

522
A Protocol for Roux-en-Y Gastric Bypass in Rats using Linear Staplers
11:58

A Protocol for Roux-en-Y Gastric Bypass in Rats using Linear Staplers

Published on: August 21, 2021

5.4K
Sleeve Gastrectomy in Mice using Surgical Clips
05:16

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

6.6K

Area of Science:

  • Cardiology
  • Transplantation Surgery
  • Bariatric Medicine

Background:

  • Durable left ventricular assist devices (LVADs) are crucial for advanced heart failure patients awaiting heart transplantation (HT).
  • Obesity, indicated by a high body mass index (BMI), often disqualifies LVAD patients from HT eligibility due to donor scarcity and post-transplant complications.
  • Weight management is a critical challenge for LVAD patients needing HT.

Purpose of the Study:

  • To describe the successful weight loss outcomes in three patients with LVADs who became eligible for HT.
  • To highlight a systematic, multidisciplinary approach to guideline-driven weight loss in this specific patient population.
  • To discuss unique barriers and medical challenges encountered during weight loss for LVAD patients.

Main Methods:

  • A case series approach was used, focusing on three individuals with LVAD support.
  • Guideline-driven weight loss strategies were implemented, including aggressive methods such as meal replacements, medications, and bariatric surgery.
  • A systematic, multidisciplinary team managed the weight loss interventions.

Main Results:

  • All three patients successfully achieved significant weight loss, meeting criteria for HT listing.
  • The multidisciplinary approach facilitated guideline-driven weight management.
  • Specific barriers and medical challenges encountered during weight loss were documented.

Conclusions:

  • Multidisciplinary, guideline-driven weight loss strategies, including aggressive interventions, can enable LVAD patients to become eligible for heart transplantation.
  • Addressing obesity in LVAD patients is feasible and crucial for improving access to HT.
  • Further research into managing weight loss challenges in this population is warranted.